WAM
VERV

Weiss Asset Management’s Verve Therapeutics VERV Stock Holding History

Weiss Asset Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-538,422
Closed -$6.05M – 789
2025
Q2 		$6.05M Buy
+538,422
New +$3.07M 0.07% 150

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Weiss Asset Management's VERV Position: Q3 2025 in Review

Weiss Asset Management sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 538,422 shares — an estimated $6.05M sold.

Weiss Asset Management first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $6.05M in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Weiss Asset Management reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Weiss Asset Management sold 538,422 Verve Therapeutics shares in Q3 2025, an estimated $6.05M.
  • Weiss Asset Management first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
  • Weiss Asset Management's Verve Therapeutics position peaked at $6.05M in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Weiss Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.